Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat

Neuroscience

Volumn 274, Issue , 2014, Pages 308-317

  Robinson, C R ^a   Zhang, H ^a   Dougherty, P M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Astrocytes; Bortezomib; Microglia; Minocycline; Oxaliplatin

Indexed keywords

BORTEZOMIB; CELL PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MINOCYCLINE; OX 42 PROTEIN; OXALIPLATIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; PLATINUM COMPLEX; PYRAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; DISEASE MODEL; MALE; MICROGLIA; NONHUMAN; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; RAT; SPINAL NERVE LIGATION INJURY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; HYPERALGESIA; INJURIES; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSIOLOGY; SPINAL CORD; SPINAL NERVE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ASTROCYTES; BORONIC ACIDS; BORTEZOMIB; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERALGESIA; MALE; MICROGLIA; MINOCYCLINE; NEUROPROTECTIVE AGENTS; ORGANOPLATINUM COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; PYRAZINES; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL NERVES;

EID: 84902682337     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.05.051     Document Type: Article

References (44)

1. Araque A., Navarrete A. Glial cells in neuronal network function. Philos Trans R Soc Lond B Biol Sci 2010, 365:2375-2381.
2. Boche D., Perry V.H., Nicoll J.A. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 2013, 39:3-18.
3. Boyette-Davis J., Dougherty P.M. Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp Neurol 2011, 229:353-357.
4. Boyette-Davis J., Xin W., Zhang H., Dougherty P.M. Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline. Pain 2011, 152:308-313.
5. Boyette-Davis J.A., Cata J.P., Driver L.C., Novy D.M., Bruel B.M., Mooring D.L., Wendelschafer-Crabb G., Kennedy W.R., Dougherty P.M. Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine. Cancer Chemother Pharmacol 2013, 71:619-626.
6. Bradesi S. Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol Motil 2010, 22:499-511.
7. Cata J.P., Weng H.R., Lee B.N., Reuben J.M., Dougherty P.M. Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol 2006, 72:151-169.
8. Cata J.P., Weng H.R., Chen J.H., Dougherty P.M. Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neuroscience 2006, 138:329-338.
9. Cata J.P., Weng H.R., Burton A.W., Villareal H., Giralt S., Dougherty P.M. Quantitative sensory findings in patients with bortezomib-induced pain. J Pain 2007, 8:296-306.
10. Cata J.P., Weng H.R., Dougherty P.M. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res 2008, 1229:100-110.
11. Cavaletti G., Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 2010, 6:657-666.
12. Di Cesare Mannelli L., Pacini A., Bonaccini L., Zanardelli M., Mello T., Ghelardini C. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J Pain 2013, 14:1585-1600.
13. Dougherty P.M., Cata J.P., Burton A.W., Vu K., Weng H.R. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J Pain Symptom Manage 2007, 33:166-179.
14. Ducourneau V.R., Dolique T., Hachem-Delaunay S., Miraucourt L.S., Amadio A., Blaszczyk L., Jacquot F., Ly J., Devoize L., Oliet S.H., Dallel R., Mothet J.P., Nagy F., Fenelon V.S., Voisin D.L. Cancer pain is not necessarily correlated with spinal overexpression of reactive glia markers. Pain 2014, 155:275-291.
15. Gao Y.J., Ji R.R. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010, 7:482-493.
16. Garner SE, Eady A, Bennett C, Newton JN, Thomas K, Popescu CM (2012), Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 8.
17. Garrison C.J., Dougherty P.M., Kajander K.C., Carlton S.M. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991, 565:1-7.
18. Graeber M.B. Changing face of microglia. Science 2010, 330:783-788.
19. Guasti L., Richardson D., Jhaveri M., Eldeeb K., Barrett D., Elphick M.R., Alexander S.P., Kendall D., Michael G.J., Chapman V. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol Pain 2009, 5:35.
20. Guerrero A.R., Uchida K., Nakajima H., Watanabe S., Nakamura M., Johnson W.E., Baba H. Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation 2012, 9:40.
21. Hald A. Spinal astrogliosis in pain models: cause and effects. Cell Mol Neurobiol 2009, 29:609-619.
22. Hu X., Li P., Guo Y., Wang H., Leak R.K., Chen S., Gao Y., Chen J. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012, 43:3063-3070.
23. Hua X.Y., Svensson C.I., Matsui T., Fitzsimmons B., Yaksh T.L., Webb M. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci 2005, 22:2431-2440.
24. Ji R.R., Suter M.R. P38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007, 3:33.
25. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363.
26. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115:71-83.
27. Liaw W.J., Stephens R.L., Binns B.C., Chu Y., Sepkuty J.P., Johns R.A., Rothstein J.D., Tao Y.X. Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 2005, 115:60-70.
28. Mao-Ying Q.L., Wang X.W., Yang C.J., Li X., Mi W.L., Wu G.C., Wang Y.Q. Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats. Mol Brain 2012, 5:16.
29. Miller RJ, Jung H, Bhangoo SK, White FA (2009), Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 419-449.
30. Nie H., Zhang H., Weng H.R. Bidrectional neuron-glia interactions triggered by deficiency of glutamate uptake at spinal sensory synapses. J Neurophysiol 2010, 104:713-725.
31. Ryu J.K., Franciosi S., Sattayaprasert P., Kim S.U., McLarnon J.G. Minocycline inhibits neuronal death and glial activation induced by β-amyloid peptide in rat hippocampus. Glia 2004, 48:85-90.
32. Sivilotti L., Woolf C.J. The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J Neurophysiol 1994, 72:169-179.
33. Sung B., Lim G., Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain rats. J Neurosci 2003, 23:2899-2910.
34. Sung C.S., Cherng C.H., Wen Z.H., Chang W.K., Huang S.Y., Lin S.L., Chan K.H., Wong C.S. Minocycline and fluorocitrate suppress spinal nociceptive signaling in intrathecal IL-1β-induced thermal hyperalgesic rats. Glia 2012, 60:2004-2017.
35. Teng Y.D., Choi H., Onario R.C., Zhu S., Desilets F.C., Lan S., Woodard E.J., Snyder E.Y., Eichler M.E., Friedlander R.M. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A 2004, 101:3071-3076.
36. Weng H.R., Aravindan N., Cata J.P., Chen J.H., Shaw A.D., Dougherty P.M. Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia. Neurosci Lett 2005, 386:18-22.
37. Xin W.J., Weng H.R., Dougherty P.M. Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation. Mol Pain 2009, 5:15.
38. Yoon S.Y., Robinson C.R., Zhang H., Dougherty P.M. Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity. J Pain 2013, 14:205-214.
39. Yrjänheikki J., Tikka T., Keinänen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 1999, 96:13496-13500.
40. Zhang H., Xin W., Dougherty P.M. Synaptically evoked glutamate transporter currents in Spinal Dorsal Horn Astrocytes. Mol Pain 2009, 5:36.
41. Zhang D., Hu X., Qian L., O'Callaghan J.P., Hong J.S. Astrogliosis in CNS pathologies: is there a role for microglia?. Mol Neurobiol 2010, 41:232-241.
42. Zhang H., Yoon S.Y., Zhang H., Dougherty P.M. Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy. J Pain 2012, 13:293-303.
43. Zheng F.Y., Xiao W.H., Bennett G.J. The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience 2011, 176:447-454.
44. Zhuang Z.Y., Kawasaki Y., Tan P.H., Wen Y.R., Huang J., Ji R.R. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 2007, 21:642-651.